Therefore, to increase the efficiency of the clinical treatment, it is necessary to further explore the mechanism of EGFR-TKI response of breast cancer and assess multi-kinase inhibitors for combinational therapy, such as E1A gene therapy. Here, EGFR is linked to breast cancer.